Global Gabapentin Drug Market Research Report 2024(Status and Outlook)
Report Overview:
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The Global Gabapentin Drug Market Size was estimated at USD 1609.25 million in 2023 and is projected to reach USD 1989.67 million by 2029, exhibiting a CAGR of 3.60% during the forecast period.
This report provides a deep insight into the global Gabapentin Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gabapentin Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gabapentin Drug market in any manner.
Global Gabapentin Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited
Market Segmentation (by Type)
Capsule
Tablet
Oral Solution
Market Segmentation (by Application)
Postherpetic Neuralgia in Adults
Partial Onset Seizures
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gabapentin Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The Global Gabapentin Drug Market Size was estimated at USD 1609.25 million in 2023 and is projected to reach USD 1989.67 million by 2029, exhibiting a CAGR of 3.60% during the forecast period.
This report provides a deep insight into the global Gabapentin Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gabapentin Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gabapentin Drug market in any manner.
Global Gabapentin Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited
Market Segmentation (by Type)
Capsule
Tablet
Oral Solution
Market Segmentation (by Application)
Postherpetic Neuralgia in Adults
Partial Onset Seizures
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gabapentin Drug Market
- Overview of the regional outlook of the Gabapentin Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gabapentin Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gabapentin Drug
1.2 Key Market Segments
1.2.1 Gabapentin Drug Segment by Type
1.2.2 Gabapentin Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GABAPENTIN DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gabapentin Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gabapentin Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GABAPENTIN DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Gabapentin Drug Sales by Manufacturers (2019-2024)
3.2 Global Gabapentin Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gabapentin Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gabapentin Drug Sales Sites, Area Served, Product Type
3.6 Gabapentin Drug Market Competitive Situation and Trends
3.6.1 Gabapentin Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gabapentin Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GABAPENTIN DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gabapentin Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GABAPENTIN DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GABAPENTIN DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gabapentin Drug Sales Market Share by Type (2019-2024)
6.3 Global Gabapentin Drug Market Size Market Share by Type (2019-2024)
6.4 Global Gabapentin Drug Price by Type (2019-2024)
7 GABAPENTIN DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gabapentin Drug Market Sales by Application (2019-2024)
7.3 Global Gabapentin Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Gabapentin Drug Sales Growth Rate by Application (2019-2024)
8 GABAPENTIN DRUG MARKET SEGMENTATION BY REGION
8.1 Global Gabapentin Drug Sales by Region
8.1.1 Global Gabapentin Drug Sales by Region
8.1.2 Global Gabapentin Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Gabapentin Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gabapentin Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gabapentin Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gabapentin Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gabapentin Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Gabapentin Drug Basic Information
9.1.2 Pfizer Gabapentin Drug Product Overview
9.1.3 Pfizer Gabapentin Drug Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Gabapentin Drug SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Depomed
9.2.1 Depomed Gabapentin Drug Basic Information
9.2.2 Depomed Gabapentin Drug Product Overview
9.2.3 Depomed Gabapentin Drug Product Market Performance
9.2.4 Depomed Business Overview
9.2.5 Depomed Gabapentin Drug SWOT Analysis
9.2.6 Depomed Recent Developments
9.3 Apotex
9.3.1 Apotex Gabapentin Drug Basic Information
9.3.2 Apotex Gabapentin Drug Product Overview
9.3.3 Apotex Gabapentin Drug Product Market Performance
9.3.4 Apotex Gabapentin Drug SWOT Analysis
9.3.5 Apotex Business Overview
9.3.6 Apotex Recent Developments
9.4 Teva
9.4.1 Teva Gabapentin Drug Basic Information
9.4.2 Teva Gabapentin Drug Product Overview
9.4.3 Teva Gabapentin Drug Product Market Performance
9.4.4 Teva Business Overview
9.4.5 Teva Recent Developments
9.5 Acella Pharmaceuticals
9.5.1 Acella Pharmaceuticals Gabapentin Drug Basic Information
9.5.2 Acella Pharmaceuticals Gabapentin Drug Product Overview
9.5.3 Acella Pharmaceuticals Gabapentin Drug Product Market Performance
9.5.4 Acella Pharmaceuticals Business Overview
9.5.5 Acella Pharmaceuticals Recent Developments
9.6 Taro
9.6.1 Taro Gabapentin Drug Basic Information
9.6.2 Taro Gabapentin Drug Product Overview
9.6.3 Taro Gabapentin Drug Product Market Performance
9.6.4 Taro Business Overview
9.6.5 Taro Recent Developments
9.7 Sun Pharmaceutical
9.7.1 Sun Pharmaceutical Gabapentin Drug Basic Information
9.7.2 Sun Pharmaceutical Gabapentin Drug Product Overview
9.7.3 Sun Pharmaceutical Gabapentin Drug Product Market Performance
9.7.4 Sun Pharmaceutical Business Overview
9.7.5 Sun Pharmaceutical Recent Developments
9.8 Glenmark
9.8.1 Glenmark Gabapentin Drug Basic Information
9.8.2 Glenmark Gabapentin Drug Product Overview
9.8.3 Glenmark Gabapentin Drug Product Market Performance
9.8.4 Glenmark Business Overview
9.8.5 Glenmark Recent Developments
9.9 Amneal Pharmaceuticals
9.9.1 Amneal Pharmaceuticals Gabapentin Drug Basic Information
9.9.2 Amneal Pharmaceuticals Gabapentin Drug Product Overview
9.9.3 Amneal Pharmaceuticals Gabapentin Drug Product Market Performance
9.9.4 Amneal Pharmaceuticals Business Overview
9.9.5 Amneal Pharmaceuticals Recent Developments
9.10 Aurobindo Pharma
9.10.1 Aurobindo Pharma Gabapentin Drug Basic Information
9.10.2 Aurobindo Pharma Gabapentin Drug Product Overview
9.10.3 Aurobindo Pharma Gabapentin Drug Product Market Performance
9.10.4 Aurobindo Pharma Business Overview
9.10.5 Aurobindo Pharma Recent Developments
9.11 Zydus Pharmaceuticals
9.11.1 Zydus Pharmaceuticals Gabapentin Drug Basic Information
9.11.2 Zydus Pharmaceuticals Gabapentin Drug Product Overview
9.11.3 Zydus Pharmaceuticals Gabapentin Drug Product Market Performance
9.11.4 Zydus Pharmaceuticals Business Overview
9.11.5 Zydus Pharmaceuticals Recent Developments
9.12 Hi-Tech Pharmaceuticals
9.12.1 Hi-Tech Pharmaceuticals Gabapentin Drug Basic Information
9.12.2 Hi-Tech Pharmaceuticals Gabapentin Drug Product Overview
9.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Product Market Performance
9.12.4 Hi-Tech Pharmaceuticals Business Overview
9.12.5 Hi-Tech Pharmaceuticals Recent Developments
9.13 Marksans Pharma
9.13.1 Marksans Pharma Gabapentin Drug Basic Information
9.13.2 Marksans Pharma Gabapentin Drug Product Overview
9.13.3 Marksans Pharma Gabapentin Drug Product Market Performance
9.13.4 Marksans Pharma Business Overview
9.13.5 Marksans Pharma Recent Developments
9.14 Mylan
9.14.1 Mylan Gabapentin Drug Basic Information
9.14.2 Mylan Gabapentin Drug Product Overview
9.14.3 Mylan Gabapentin Drug Product Market Performance
9.14.4 Mylan Business Overview
9.14.5 Mylan Recent Developments
9.15 InvaGen Pharmaceuticals
9.15.1 InvaGen Pharmaceuticals Gabapentin Drug Basic Information
9.15.2 InvaGen Pharmaceuticals Gabapentin Drug Product Overview
9.15.3 InvaGen Pharmaceuticals Gabapentin Drug Product Market Performance
9.15.4 InvaGen Pharmaceuticals Business Overview
9.15.5 InvaGen Pharmaceuticals Recent Developments
9.16 Alkem Laboratories
9.16.1 Alkem Laboratories Gabapentin Drug Basic Information
9.16.2 Alkem Laboratories Gabapentin Drug Product Overview
9.16.3 Alkem Laboratories Gabapentin Drug Product Market Performance
9.16.4 Alkem Laboratories Business Overview
9.16.5 Alkem Laboratories Recent Developments
9.17 Tris Pharma
9.17.1 Tris Pharma Gabapentin Drug Basic Information
9.17.2 Tris Pharma Gabapentin Drug Product Overview
9.17.3 Tris Pharma Gabapentin Drug Product Market Performance
9.17.4 Tris Pharma Business Overview
9.17.5 Tris Pharma Recent Developments
9.18 ACI HealthCare Limited
9.18.1 ACI HealthCare Limited Gabapentin Drug Basic Information
9.18.2 ACI HealthCare Limited Gabapentin Drug Product Overview
9.18.3 ACI HealthCare Limited Gabapentin Drug Product Market Performance
9.18.4 ACI HealthCare Limited Business Overview
9.18.5 ACI HealthCare Limited Recent Developments
9.19 Jiangsu Hengrui Medicine
9.19.1 Jiangsu Hengrui Medicine Gabapentin Drug Basic Information
9.19.2 Jiangsu Hengrui Medicine Gabapentin Drug Product Overview
9.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Product Market Performance
9.19.4 Jiangsu Hengrui Medicine Business Overview
9.19.5 Jiangsu Hengrui Medicine Recent Developments
9.20 CSPC Ouyi Pharmaceutical
9.20.1 CSPC Ouyi Pharmaceutical Gabapentin Drug Basic Information
9.20.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Overview
9.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Market Performance
9.20.4 CSPC Ouyi Pharmaceutical Business Overview
9.20.5 CSPC Ouyi Pharmaceutical Recent Developments
9.21 Sciegen Pharmaceuticals
9.21.1 Sciegen Pharmaceuticals Gabapentin Drug Basic Information
9.21.2 Sciegen Pharmaceuticals Gabapentin Drug Product Overview
9.21.3 Sciegen Pharmaceuticals Gabapentin Drug Product Market Performance
9.21.4 Sciegen Pharmaceuticals Business Overview
9.21.5 Sciegen Pharmaceuticals Recent Developments
9.22 Epic Pharma
9.22.1 Epic Pharma Gabapentin Drug Basic Information
9.22.2 Epic Pharma Gabapentin Drug Product Overview
9.22.3 Epic Pharma Gabapentin Drug Product Market Performance
9.22.4 Epic Pharma Business Overview
9.22.5 Epic Pharma Recent Developments
9.23 Lupin Limited
9.23.1 Lupin Limited Gabapentin Drug Basic Information
9.23.2 Lupin Limited Gabapentin Drug Product Overview
9.23.3 Lupin Limited Gabapentin Drug Product Market Performance
9.23.4 Lupin Limited Business Overview
9.23.5 Lupin Limited Recent Developments
10 GABAPENTIN DRUG MARKET FORECAST BY REGION
10.1 Global Gabapentin Drug Market Size Forecast
10.2 Global Gabapentin Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gabapentin Drug Market Size Forecast by Country
10.2.3 Asia Pacific Gabapentin Drug Market Size Forecast by Region
10.2.4 South America Gabapentin Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gabapentin Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gabapentin Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gabapentin Drug by Type (2025-2030)
11.1.2 Global Gabapentin Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gabapentin Drug by Type (2025-2030)
11.2 Global Gabapentin Drug Market Forecast by Application (2025-2030)
11.2.1 Global Gabapentin Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Gabapentin Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gabapentin Drug
1.2 Key Market Segments
1.2.1 Gabapentin Drug Segment by Type
1.2.2 Gabapentin Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GABAPENTIN DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gabapentin Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gabapentin Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GABAPENTIN DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Gabapentin Drug Sales by Manufacturers (2019-2024)
3.2 Global Gabapentin Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gabapentin Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gabapentin Drug Sales Sites, Area Served, Product Type
3.6 Gabapentin Drug Market Competitive Situation and Trends
3.6.1 Gabapentin Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gabapentin Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GABAPENTIN DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gabapentin Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GABAPENTIN DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GABAPENTIN DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gabapentin Drug Sales Market Share by Type (2019-2024)
6.3 Global Gabapentin Drug Market Size Market Share by Type (2019-2024)
6.4 Global Gabapentin Drug Price by Type (2019-2024)
7 GABAPENTIN DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gabapentin Drug Market Sales by Application (2019-2024)
7.3 Global Gabapentin Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Gabapentin Drug Sales Growth Rate by Application (2019-2024)
8 GABAPENTIN DRUG MARKET SEGMENTATION BY REGION
8.1 Global Gabapentin Drug Sales by Region
8.1.1 Global Gabapentin Drug Sales by Region
8.1.2 Global Gabapentin Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Gabapentin Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gabapentin Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gabapentin Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gabapentin Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gabapentin Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Gabapentin Drug Basic Information
9.1.2 Pfizer Gabapentin Drug Product Overview
9.1.3 Pfizer Gabapentin Drug Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Gabapentin Drug SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Depomed
9.2.1 Depomed Gabapentin Drug Basic Information
9.2.2 Depomed Gabapentin Drug Product Overview
9.2.3 Depomed Gabapentin Drug Product Market Performance
9.2.4 Depomed Business Overview
9.2.5 Depomed Gabapentin Drug SWOT Analysis
9.2.6 Depomed Recent Developments
9.3 Apotex
9.3.1 Apotex Gabapentin Drug Basic Information
9.3.2 Apotex Gabapentin Drug Product Overview
9.3.3 Apotex Gabapentin Drug Product Market Performance
9.3.4 Apotex Gabapentin Drug SWOT Analysis
9.3.5 Apotex Business Overview
9.3.6 Apotex Recent Developments
9.4 Teva
9.4.1 Teva Gabapentin Drug Basic Information
9.4.2 Teva Gabapentin Drug Product Overview
9.4.3 Teva Gabapentin Drug Product Market Performance
9.4.4 Teva Business Overview
9.4.5 Teva Recent Developments
9.5 Acella Pharmaceuticals
9.5.1 Acella Pharmaceuticals Gabapentin Drug Basic Information
9.5.2 Acella Pharmaceuticals Gabapentin Drug Product Overview
9.5.3 Acella Pharmaceuticals Gabapentin Drug Product Market Performance
9.5.4 Acella Pharmaceuticals Business Overview
9.5.5 Acella Pharmaceuticals Recent Developments
9.6 Taro
9.6.1 Taro Gabapentin Drug Basic Information
9.6.2 Taro Gabapentin Drug Product Overview
9.6.3 Taro Gabapentin Drug Product Market Performance
9.6.4 Taro Business Overview
9.6.5 Taro Recent Developments
9.7 Sun Pharmaceutical
9.7.1 Sun Pharmaceutical Gabapentin Drug Basic Information
9.7.2 Sun Pharmaceutical Gabapentin Drug Product Overview
9.7.3 Sun Pharmaceutical Gabapentin Drug Product Market Performance
9.7.4 Sun Pharmaceutical Business Overview
9.7.5 Sun Pharmaceutical Recent Developments
9.8 Glenmark
9.8.1 Glenmark Gabapentin Drug Basic Information
9.8.2 Glenmark Gabapentin Drug Product Overview
9.8.3 Glenmark Gabapentin Drug Product Market Performance
9.8.4 Glenmark Business Overview
9.8.5 Glenmark Recent Developments
9.9 Amneal Pharmaceuticals
9.9.1 Amneal Pharmaceuticals Gabapentin Drug Basic Information
9.9.2 Amneal Pharmaceuticals Gabapentin Drug Product Overview
9.9.3 Amneal Pharmaceuticals Gabapentin Drug Product Market Performance
9.9.4 Amneal Pharmaceuticals Business Overview
9.9.5 Amneal Pharmaceuticals Recent Developments
9.10 Aurobindo Pharma
9.10.1 Aurobindo Pharma Gabapentin Drug Basic Information
9.10.2 Aurobindo Pharma Gabapentin Drug Product Overview
9.10.3 Aurobindo Pharma Gabapentin Drug Product Market Performance
9.10.4 Aurobindo Pharma Business Overview
9.10.5 Aurobindo Pharma Recent Developments
9.11 Zydus Pharmaceuticals
9.11.1 Zydus Pharmaceuticals Gabapentin Drug Basic Information
9.11.2 Zydus Pharmaceuticals Gabapentin Drug Product Overview
9.11.3 Zydus Pharmaceuticals Gabapentin Drug Product Market Performance
9.11.4 Zydus Pharmaceuticals Business Overview
9.11.5 Zydus Pharmaceuticals Recent Developments
9.12 Hi-Tech Pharmaceuticals
9.12.1 Hi-Tech Pharmaceuticals Gabapentin Drug Basic Information
9.12.2 Hi-Tech Pharmaceuticals Gabapentin Drug Product Overview
9.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Product Market Performance
9.12.4 Hi-Tech Pharmaceuticals Business Overview
9.12.5 Hi-Tech Pharmaceuticals Recent Developments
9.13 Marksans Pharma
9.13.1 Marksans Pharma Gabapentin Drug Basic Information
9.13.2 Marksans Pharma Gabapentin Drug Product Overview
9.13.3 Marksans Pharma Gabapentin Drug Product Market Performance
9.13.4 Marksans Pharma Business Overview
9.13.5 Marksans Pharma Recent Developments
9.14 Mylan
9.14.1 Mylan Gabapentin Drug Basic Information
9.14.2 Mylan Gabapentin Drug Product Overview
9.14.3 Mylan Gabapentin Drug Product Market Performance
9.14.4 Mylan Business Overview
9.14.5 Mylan Recent Developments
9.15 InvaGen Pharmaceuticals
9.15.1 InvaGen Pharmaceuticals Gabapentin Drug Basic Information
9.15.2 InvaGen Pharmaceuticals Gabapentin Drug Product Overview
9.15.3 InvaGen Pharmaceuticals Gabapentin Drug Product Market Performance
9.15.4 InvaGen Pharmaceuticals Business Overview
9.15.5 InvaGen Pharmaceuticals Recent Developments
9.16 Alkem Laboratories
9.16.1 Alkem Laboratories Gabapentin Drug Basic Information
9.16.2 Alkem Laboratories Gabapentin Drug Product Overview
9.16.3 Alkem Laboratories Gabapentin Drug Product Market Performance
9.16.4 Alkem Laboratories Business Overview
9.16.5 Alkem Laboratories Recent Developments
9.17 Tris Pharma
9.17.1 Tris Pharma Gabapentin Drug Basic Information
9.17.2 Tris Pharma Gabapentin Drug Product Overview
9.17.3 Tris Pharma Gabapentin Drug Product Market Performance
9.17.4 Tris Pharma Business Overview
9.17.5 Tris Pharma Recent Developments
9.18 ACI HealthCare Limited
9.18.1 ACI HealthCare Limited Gabapentin Drug Basic Information
9.18.2 ACI HealthCare Limited Gabapentin Drug Product Overview
9.18.3 ACI HealthCare Limited Gabapentin Drug Product Market Performance
9.18.4 ACI HealthCare Limited Business Overview
9.18.5 ACI HealthCare Limited Recent Developments
9.19 Jiangsu Hengrui Medicine
9.19.1 Jiangsu Hengrui Medicine Gabapentin Drug Basic Information
9.19.2 Jiangsu Hengrui Medicine Gabapentin Drug Product Overview
9.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Product Market Performance
9.19.4 Jiangsu Hengrui Medicine Business Overview
9.19.5 Jiangsu Hengrui Medicine Recent Developments
9.20 CSPC Ouyi Pharmaceutical
9.20.1 CSPC Ouyi Pharmaceutical Gabapentin Drug Basic Information
9.20.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Overview
9.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Market Performance
9.20.4 CSPC Ouyi Pharmaceutical Business Overview
9.20.5 CSPC Ouyi Pharmaceutical Recent Developments
9.21 Sciegen Pharmaceuticals
9.21.1 Sciegen Pharmaceuticals Gabapentin Drug Basic Information
9.21.2 Sciegen Pharmaceuticals Gabapentin Drug Product Overview
9.21.3 Sciegen Pharmaceuticals Gabapentin Drug Product Market Performance
9.21.4 Sciegen Pharmaceuticals Business Overview
9.21.5 Sciegen Pharmaceuticals Recent Developments
9.22 Epic Pharma
9.22.1 Epic Pharma Gabapentin Drug Basic Information
9.22.2 Epic Pharma Gabapentin Drug Product Overview
9.22.3 Epic Pharma Gabapentin Drug Product Market Performance
9.22.4 Epic Pharma Business Overview
9.22.5 Epic Pharma Recent Developments
9.23 Lupin Limited
9.23.1 Lupin Limited Gabapentin Drug Basic Information
9.23.2 Lupin Limited Gabapentin Drug Product Overview
9.23.3 Lupin Limited Gabapentin Drug Product Market Performance
9.23.4 Lupin Limited Business Overview
9.23.5 Lupin Limited Recent Developments
10 GABAPENTIN DRUG MARKET FORECAST BY REGION
10.1 Global Gabapentin Drug Market Size Forecast
10.2 Global Gabapentin Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gabapentin Drug Market Size Forecast by Country
10.2.3 Asia Pacific Gabapentin Drug Market Size Forecast by Region
10.2.4 South America Gabapentin Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gabapentin Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gabapentin Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gabapentin Drug by Type (2025-2030)
11.1.2 Global Gabapentin Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gabapentin Drug by Type (2025-2030)
11.2 Global Gabapentin Drug Market Forecast by Application (2025-2030)
11.2.1 Global Gabapentin Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Gabapentin Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gabapentin Drug Market Size Comparison by Region (M USD)
Table 5. Global Gabapentin Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gabapentin Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gabapentin Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gabapentin Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2022)
Table 10. Global Market Gabapentin Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gabapentin Drug Sales Sites and Area Served
Table 12. Manufacturers Gabapentin Drug Product Type
Table 13. Global Gabapentin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gabapentin Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gabapentin Drug Market Challenges
Table 22. Global Gabapentin Drug Sales by Type (Kilotons)
Table 23. Global Gabapentin Drug Market Size by Type (M USD)
Table 24. Global Gabapentin Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gabapentin Drug Sales Market Share by Type (2019-2024)
Table 26. Global Gabapentin Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Gabapentin Drug Market Size Share by Type (2019-2024)
Table 28. Global Gabapentin Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gabapentin Drug Sales (Kilotons) by Application
Table 30. Global Gabapentin Drug Market Size by Application
Table 31. Global Gabapentin Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gabapentin Drug Sales Market Share by Application (2019-2024)
Table 33. Global Gabapentin Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Gabapentin Drug Market Share by Application (2019-2024)
Table 35. Global Gabapentin Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Gabapentin Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gabapentin Drug Sales Market Share by Region (2019-2024)
Table 38. North America Gabapentin Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gabapentin Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gabapentin Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gabapentin Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gabapentin Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Gabapentin Drug Basic Information
Table 44. Pfizer Gabapentin Drug Product Overview
Table 45. Pfizer Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Gabapentin Drug SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Depomed Gabapentin Drug Basic Information
Table 50. Depomed Gabapentin Drug Product Overview
Table 51. Depomed Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Depomed Business Overview
Table 53. Depomed Gabapentin Drug SWOT Analysis
Table 54. Depomed Recent Developments
Table 55. Apotex Gabapentin Drug Basic Information
Table 56. Apotex Gabapentin Drug Product Overview
Table 57. Apotex Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Apotex Gabapentin Drug SWOT Analysis
Table 59. Apotex Business Overview
Table 60. Apotex Recent Developments
Table 61. Teva Gabapentin Drug Basic Information
Table 62. Teva Gabapentin Drug Product Overview
Table 63. Teva Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Teva Business Overview
Table 65. Teva Recent Developments
Table 66. Acella Pharmaceuticals Gabapentin Drug Basic Information
Table 67. Acella Pharmaceuticals Gabapentin Drug Product Overview
Table 68. Acella Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Acella Pharmaceuticals Business Overview
Table 70. Acella Pharmaceuticals Recent Developments
Table 71. Taro Gabapentin Drug Basic Information
Table 72. Taro Gabapentin Drug Product Overview
Table 73. Taro Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Taro Business Overview
Table 75. Taro Recent Developments
Table 76. Sun Pharmaceutical Gabapentin Drug Basic Information
Table 77. Sun Pharmaceutical Gabapentin Drug Product Overview
Table 78. Sun Pharmaceutical Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Sun Pharmaceutical Business Overview
Table 80. Sun Pharmaceutical Recent Developments
Table 81. Glenmark Gabapentin Drug Basic Information
Table 82. Glenmark Gabapentin Drug Product Overview
Table 83. Glenmark Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Glenmark Business Overview
Table 85. Glenmark Recent Developments
Table 86. Amneal Pharmaceuticals Gabapentin Drug Basic Information
Table 87. Amneal Pharmaceuticals Gabapentin Drug Product Overview
Table 88. Amneal Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Amneal Pharmaceuticals Business Overview
Table 90. Amneal Pharmaceuticals Recent Developments
Table 91. Aurobindo Pharma Gabapentin Drug Basic Information
Table 92. Aurobindo Pharma Gabapentin Drug Product Overview
Table 93. Aurobindo Pharma Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Aurobindo Pharma Business Overview
Table 95. Aurobindo Pharma Recent Developments
Table 96. Zydus Pharmaceuticals Gabapentin Drug Basic Information
Table 97. Zydus Pharmaceuticals Gabapentin Drug Product Overview
Table 98. Zydus Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Zydus Pharmaceuticals Business Overview
Table 100. Zydus Pharmaceuticals Recent Developments
Table 101. Hi-Tech Pharmaceuticals Gabapentin Drug Basic Information
Table 102. Hi-Tech Pharmaceuticals Gabapentin Drug Product Overview
Table 103. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Hi-Tech Pharmaceuticals Business Overview
Table 105. Hi-Tech Pharmaceuticals Recent Developments
Table 106. Marksans Pharma Gabapentin Drug Basic Information
Table 107. Marksans Pharma Gabapentin Drug Product Overview
Table 108. Marksans Pharma Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Marksans Pharma Business Overview
Table 110. Marksans Pharma Recent Developments
Table 111. Mylan Gabapentin Drug Basic Information
Table 112. Mylan Gabapentin Drug Product Overview
Table 113. Mylan Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Mylan Business Overview
Table 115. Mylan Recent Developments
Table 116. InvaGen Pharmaceuticals Gabapentin Drug Basic Information
Table 117. InvaGen Pharmaceuticals Gabapentin Drug Product Overview
Table 118. InvaGen Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. InvaGen Pharmaceuticals Business Overview
Table 120. InvaGen Pharmaceuticals Recent Developments
Table 121. Alkem Laboratories Gabapentin Drug Basic Information
Table 122. Alkem Laboratories Gabapentin Drug Product Overview
Table 123. Alkem Laboratories Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Alkem Laboratories Business Overview
Table 125. Alkem Laboratories Recent Developments
Table 126. Tris Pharma Gabapentin Drug Basic Information
Table 127. Tris Pharma Gabapentin Drug Product Overview
Table 128. Tris Pharma Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Tris Pharma Business Overview
Table 130. Tris Pharma Recent Developments
Table 131. ACI HealthCare Limited Gabapentin Drug Basic Information
Table 132. ACI HealthCare Limited Gabapentin Drug Product Overview
Table 133. ACI HealthCare Limited Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. ACI HealthCare Limited Business Overview
Table 135. ACI HealthCare Limited Recent Developments
Table 136. Jiangsu Hengrui Medicine Gabapentin Drug Basic Information
Table 137. Jiangsu Hengrui Medicine Gabapentin Drug Product Overview
Table 138. Jiangsu Hengrui Medicine Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Jiangsu Hengrui Medicine Business Overview
Table 140. Jiangsu Hengrui Medicine Recent Developments
Table 141. CSPC Ouyi Pharmaceutical Gabapentin Drug Basic Information
Table 142. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Overview
Table 143. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. CSPC Ouyi Pharmaceutical Business Overview
Table 145. CSPC Ouyi Pharmaceutical Recent Developments
Table 146. Sciegen Pharmaceuticals Gabapentin Drug Basic Information
Table 147. Sciegen Pharmaceuticals Gabapentin Drug Product Overview
Table 148. Sciegen Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Sciegen Pharmaceuticals Business Overview
Table 150. Sciegen Pharmaceuticals Recent Developments
Table 151. Epic Pharma Gabapentin Drug Basic Information
Table 152. Epic Pharma Gabapentin Drug Product Overview
Table 153. Epic Pharma Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. Epic Pharma Business Overview
Table 155. Epic Pharma Recent Developments
Table 156. Lupin Limited Gabapentin Drug Basic Information
Table 157. Lupin Limited Gabapentin Drug Product Overview
Table 158. Lupin Limited Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 159. Lupin Limited Business Overview
Table 160. Lupin Limited Recent Developments
Table 161. Global Gabapentin Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 162. Global Gabapentin Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Gabapentin Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 164. North America Gabapentin Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Gabapentin Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 166. Europe Gabapentin Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Gabapentin Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 168. Asia Pacific Gabapentin Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Gabapentin Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 170. South America Gabapentin Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Gabapentin Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Gabapentin Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Gabapentin Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 174. Global Gabapentin Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Gabapentin Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 176. Global Gabapentin Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 177. Global Gabapentin Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gabapentin Drug Market Size Comparison by Region (M USD)
Table 5. Global Gabapentin Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gabapentin Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gabapentin Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gabapentin Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2022)
Table 10. Global Market Gabapentin Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gabapentin Drug Sales Sites and Area Served
Table 12. Manufacturers Gabapentin Drug Product Type
Table 13. Global Gabapentin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gabapentin Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gabapentin Drug Market Challenges
Table 22. Global Gabapentin Drug Sales by Type (Kilotons)
Table 23. Global Gabapentin Drug Market Size by Type (M USD)
Table 24. Global Gabapentin Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gabapentin Drug Sales Market Share by Type (2019-2024)
Table 26. Global Gabapentin Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Gabapentin Drug Market Size Share by Type (2019-2024)
Table 28. Global Gabapentin Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gabapentin Drug Sales (Kilotons) by Application
Table 30. Global Gabapentin Drug Market Size by Application
Table 31. Global Gabapentin Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gabapentin Drug Sales Market Share by Application (2019-2024)
Table 33. Global Gabapentin Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Gabapentin Drug Market Share by Application (2019-2024)
Table 35. Global Gabapentin Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Gabapentin Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gabapentin Drug Sales Market Share by Region (2019-2024)
Table 38. North America Gabapentin Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gabapentin Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gabapentin Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gabapentin Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gabapentin Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Gabapentin Drug Basic Information
Table 44. Pfizer Gabapentin Drug Product Overview
Table 45. Pfizer Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Gabapentin Drug SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Depomed Gabapentin Drug Basic Information
Table 50. Depomed Gabapentin Drug Product Overview
Table 51. Depomed Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Depomed Business Overview
Table 53. Depomed Gabapentin Drug SWOT Analysis
Table 54. Depomed Recent Developments
Table 55. Apotex Gabapentin Drug Basic Information
Table 56. Apotex Gabapentin Drug Product Overview
Table 57. Apotex Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Apotex Gabapentin Drug SWOT Analysis
Table 59. Apotex Business Overview
Table 60. Apotex Recent Developments
Table 61. Teva Gabapentin Drug Basic Information
Table 62. Teva Gabapentin Drug Product Overview
Table 63. Teva Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Teva Business Overview
Table 65. Teva Recent Developments
Table 66. Acella Pharmaceuticals Gabapentin Drug Basic Information
Table 67. Acella Pharmaceuticals Gabapentin Drug Product Overview
Table 68. Acella Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Acella Pharmaceuticals Business Overview
Table 70. Acella Pharmaceuticals Recent Developments
Table 71. Taro Gabapentin Drug Basic Information
Table 72. Taro Gabapentin Drug Product Overview
Table 73. Taro Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Taro Business Overview
Table 75. Taro Recent Developments
Table 76. Sun Pharmaceutical Gabapentin Drug Basic Information
Table 77. Sun Pharmaceutical Gabapentin Drug Product Overview
Table 78. Sun Pharmaceutical Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Sun Pharmaceutical Business Overview
Table 80. Sun Pharmaceutical Recent Developments
Table 81. Glenmark Gabapentin Drug Basic Information
Table 82. Glenmark Gabapentin Drug Product Overview
Table 83. Glenmark Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Glenmark Business Overview
Table 85. Glenmark Recent Developments
Table 86. Amneal Pharmaceuticals Gabapentin Drug Basic Information
Table 87. Amneal Pharmaceuticals Gabapentin Drug Product Overview
Table 88. Amneal Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Amneal Pharmaceuticals Business Overview
Table 90. Amneal Pharmaceuticals Recent Developments
Table 91. Aurobindo Pharma Gabapentin Drug Basic Information
Table 92. Aurobindo Pharma Gabapentin Drug Product Overview
Table 93. Aurobindo Pharma Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Aurobindo Pharma Business Overview
Table 95. Aurobindo Pharma Recent Developments
Table 96. Zydus Pharmaceuticals Gabapentin Drug Basic Information
Table 97. Zydus Pharmaceuticals Gabapentin Drug Product Overview
Table 98. Zydus Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Zydus Pharmaceuticals Business Overview
Table 100. Zydus Pharmaceuticals Recent Developments
Table 101. Hi-Tech Pharmaceuticals Gabapentin Drug Basic Information
Table 102. Hi-Tech Pharmaceuticals Gabapentin Drug Product Overview
Table 103. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Hi-Tech Pharmaceuticals Business Overview
Table 105. Hi-Tech Pharmaceuticals Recent Developments
Table 106. Marksans Pharma Gabapentin Drug Basic Information
Table 107. Marksans Pharma Gabapentin Drug Product Overview
Table 108. Marksans Pharma Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Marksans Pharma Business Overview
Table 110. Marksans Pharma Recent Developments
Table 111. Mylan Gabapentin Drug Basic Information
Table 112. Mylan Gabapentin Drug Product Overview
Table 113. Mylan Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Mylan Business Overview
Table 115. Mylan Recent Developments
Table 116. InvaGen Pharmaceuticals Gabapentin Drug Basic Information
Table 117. InvaGen Pharmaceuticals Gabapentin Drug Product Overview
Table 118. InvaGen Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. InvaGen Pharmaceuticals Business Overview
Table 120. InvaGen Pharmaceuticals Recent Developments
Table 121. Alkem Laboratories Gabapentin Drug Basic Information
Table 122. Alkem Laboratories Gabapentin Drug Product Overview
Table 123. Alkem Laboratories Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Alkem Laboratories Business Overview
Table 125. Alkem Laboratories Recent Developments
Table 126. Tris Pharma Gabapentin Drug Basic Information
Table 127. Tris Pharma Gabapentin Drug Product Overview
Table 128. Tris Pharma Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Tris Pharma Business Overview
Table 130. Tris Pharma Recent Developments
Table 131. ACI HealthCare Limited Gabapentin Drug Basic Information
Table 132. ACI HealthCare Limited Gabapentin Drug Product Overview
Table 133. ACI HealthCare Limited Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. ACI HealthCare Limited Business Overview
Table 135. ACI HealthCare Limited Recent Developments
Table 136. Jiangsu Hengrui Medicine Gabapentin Drug Basic Information
Table 137. Jiangsu Hengrui Medicine Gabapentin Drug Product Overview
Table 138. Jiangsu Hengrui Medicine Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Jiangsu Hengrui Medicine Business Overview
Table 140. Jiangsu Hengrui Medicine Recent Developments
Table 141. CSPC Ouyi Pharmaceutical Gabapentin Drug Basic Information
Table 142. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Overview
Table 143. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. CSPC Ouyi Pharmaceutical Business Overview
Table 145. CSPC Ouyi Pharmaceutical Recent Developments
Table 146. Sciegen Pharmaceuticals Gabapentin Drug Basic Information
Table 147. Sciegen Pharmaceuticals Gabapentin Drug Product Overview
Table 148. Sciegen Pharmaceuticals Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Sciegen Pharmaceuticals Business Overview
Table 150. Sciegen Pharmaceuticals Recent Developments
Table 151. Epic Pharma Gabapentin Drug Basic Information
Table 152. Epic Pharma Gabapentin Drug Product Overview
Table 153. Epic Pharma Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. Epic Pharma Business Overview
Table 155. Epic Pharma Recent Developments
Table 156. Lupin Limited Gabapentin Drug Basic Information
Table 157. Lupin Limited Gabapentin Drug Product Overview
Table 158. Lupin Limited Gabapentin Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 159. Lupin Limited Business Overview
Table 160. Lupin Limited Recent Developments
Table 161. Global Gabapentin Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 162. Global Gabapentin Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Gabapentin Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 164. North America Gabapentin Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Gabapentin Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 166. Europe Gabapentin Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Gabapentin Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 168. Asia Pacific Gabapentin Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Gabapentin Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 170. South America Gabapentin Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Gabapentin Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Gabapentin Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Gabapentin Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 174. Global Gabapentin Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Gabapentin Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 176. Global Gabapentin Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 177. Global Gabapentin Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gabapentin Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gabapentin Drug Market Size (M USD), 2019-2030
Figure 5. Global Gabapentin Drug Market Size (M USD) (2019-2030)
Figure 6. Global Gabapentin Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gabapentin Drug Market Size by Country (M USD)
Figure 11. Gabapentin Drug Sales Share by Manufacturers in 2023
Figure 12. Global Gabapentin Drug Revenue Share by Manufacturers in 2023
Figure 13. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gabapentin Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gabapentin Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gabapentin Drug Market Share by Type
Figure 18. Sales Market Share of Gabapentin Drug by Type (2019-2024)
Figure 19. Sales Market Share of Gabapentin Drug by Type in 2023
Figure 20. Market Size Share of Gabapentin Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Gabapentin Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gabapentin Drug Market Share by Application
Figure 24. Global Gabapentin Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Gabapentin Drug Sales Market Share by Application in 2023
Figure 26. Global Gabapentin Drug Market Share by Application (2019-2024)
Figure 27. Global Gabapentin Drug Market Share by Application in 2023
Figure 28. Global Gabapentin Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gabapentin Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gabapentin Drug Sales Market Share by Country in 2023
Figure 32. U.S. Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gabapentin Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gabapentin Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gabapentin Drug Sales Market Share by Country in 2023
Figure 37. Germany Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gabapentin Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gabapentin Drug Sales Market Share by Region in 2023
Figure 44. China Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gabapentin Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Gabapentin Drug Sales Market Share by Country in 2023
Figure 51. Brazil Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gabapentin Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gabapentin Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gabapentin Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gabapentin Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gabapentin Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gabapentin Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Gabapentin Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Gabapentin Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Gabapentin Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gabapentin Drug Market Size (M USD), 2019-2030
Figure 5. Global Gabapentin Drug Market Size (M USD) (2019-2030)
Figure 6. Global Gabapentin Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gabapentin Drug Market Size by Country (M USD)
Figure 11. Gabapentin Drug Sales Share by Manufacturers in 2023
Figure 12. Global Gabapentin Drug Revenue Share by Manufacturers in 2023
Figure 13. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gabapentin Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gabapentin Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gabapentin Drug Market Share by Type
Figure 18. Sales Market Share of Gabapentin Drug by Type (2019-2024)
Figure 19. Sales Market Share of Gabapentin Drug by Type in 2023
Figure 20. Market Size Share of Gabapentin Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Gabapentin Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gabapentin Drug Market Share by Application
Figure 24. Global Gabapentin Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Gabapentin Drug Sales Market Share by Application in 2023
Figure 26. Global Gabapentin Drug Market Share by Application (2019-2024)
Figure 27. Global Gabapentin Drug Market Share by Application in 2023
Figure 28. Global Gabapentin Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gabapentin Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gabapentin Drug Sales Market Share by Country in 2023
Figure 32. U.S. Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gabapentin Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gabapentin Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gabapentin Drug Sales Market Share by Country in 2023
Figure 37. Germany Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gabapentin Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gabapentin Drug Sales Market Share by Region in 2023
Figure 44. China Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gabapentin Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Gabapentin Drug Sales Market Share by Country in 2023
Figure 51. Brazil Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gabapentin Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gabapentin Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gabapentin Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gabapentin Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gabapentin Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gabapentin Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gabapentin Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Gabapentin Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Gabapentin Drug Market Share Forecast by Application (2025-2030)
